Literature DB >> 5002728

Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas.

D L Morton, F R Eilber, R A Malmgren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5002728     DOI： 10.1159/000392269

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN： 0079-6263


× No keyword cloud information.
  9 in total

Review 1.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

2.  Antigens of carcinoma of the cervix uteri. A study by means of immunofluorescence.

Authors:  D S Nelson
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

3.  Cellular immunity to breast carcinoma and malignant melanoma.

Authors:  A J Cochran; R M Mackie; C E Thomas; R M Grant; D E Cameron-Mowat; W G Spilg
Journal:  Br J Cancer Suppl       Date:  1973-08

4.  The cellular immune response to carcinoma of the urinary bladder: correlation to clinical stage and treatment.

Authors:  C O'Toole; B Unsgaard; L E Almgård; B Johansson
Journal:  Br J Cancer Suppl       Date:  1973-08

5.  The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans.

Authors:  Karin Loser; Thomas Brzoska; Vinzenz Oji; Matteo Auriemma; Maik Voskort; Verena Kupas; Lars Klenner; Cornelius Mensing; Axel Hauschild; Stefan Beissert; Thomas A Luger
Journal:  PLoS One       Date:  2010-02-01       Impact factor: 3.240

6.  The biology, pathology and immunology of a virus induced rat osteosarcoma. I. Biological behaviour and histopathology.

Authors:  A A Czitrom; F Langer; A E Gross; E P Urovitz; K P Pritzker
Journal:  Int Orthop       Date:  1980       Impact factor: 3.075

7.  Cellular localization of immunoglobulin within human maglignant melanomata.

Authors:  M G Lewis; J W Proctor; D M Thomson; G Rowden; T M Phillips
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

8.  The influence of tumour burden and therapy on cellular cytotoxicity responses in patients with ocular and skin melanoma.

Authors:  B Unsgaard; C O'Toole
Journal:  Br J Cancer       Date:  1975-03       Impact factor: 7.640

9.  Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.

Authors:  J H Marti; D M Thomson
Journal:  Br J Cancer       Date:  1976-08       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.